Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: Facilitators and Barriers to Eptinezumab Administration in Thailand

View source ↗

Summary

A completed clinical trial update examining facilitators and barriers to administering eptinezumab for migraine in Thailand.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VYEPTI (eptinezumab)

Snippet

Sponsor: Chulalongkorn University | Conditions: Migraine, Treatment | Status: COMPLETED